Clinical trial
Study for Treatment of Cancer in Children With Ataxia-telangiectasia
NCT00187057 · St. Jude Children's Research Hospital, Other · Completed
Key facts
| NCT number | NCT00187057 |
|---|---|
| Title | Study for Treatment of Cancer in Children With Ataxia-telangiectasia |
| Official title | Pilot Study I for Treatment of Cancer in Children With Ataxia-Telangiectasia |
| Lead sponsor | St. Jude Children's Research Hospital, Other |
| Collaborators | Children's Hospital of Philadelphia National Cancer Institute (NCI) NIH |
| Status | Completed |
| Study type | Interventional |
| Conditions | Ataxia-Telangiectasia |
| Intervention type | Drug, Procedure |
| Interventions | vinblastine, vincristine, prednisone, daunorubicin, doxorubicin, methotrexate, cyclophosphamide, L-asparaginase, etoposide, cytarabine and 6 more |
| Enrollment | 6 |
| Start date | Sep 1, 2002 |
| Primary completion | Aug 1, 2006 |
| Completion | Jun 1, 2013 |
| First posted | Sep 16, 2005 |
| Last update posted | Aug 27, 2015 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: